ipscell.com
Good stem cell news on trials, FDA, cool new papers & more - The Niche
In the whirlwind that is the stem cell and regenerative medicine world, there are many concerning things that need attention, but also good stuff happens too and this post focuses on the positive. The Asterias spinal cord injury clinical trial, a phase 1/2a trial called SCiStar, continues to make encouraging news with a clean safety profile … Good stem cell news on trials, FDA, cool new papers & more Read More »
Professor Paul Knoepfler, Ph.D.